Elimination of SARS-CoV-2 in nasopharynx and oropharynx after use of an adjuvant gargling and rinsing protocol with an antiseptic mouthwash.
作者信息
Vilhena Fabiano Vieira, Orcina Bernardo da Fonseca, Lemos Lúcio, Less Jeanette Cecília Fournier, Pinto Isabella, Santos Paulo Sérgio da Silva
机构信息
Trials - Saúde Bucal & Tecnologias - TRIALS, Bauru, SP, Brazil.
Faculdade de Odontologia de Bauru, Universidade de São Paulo, Bauru, SP, Brazil.
出版信息
Einstein (Sao Paulo). 2022 Jan 5;19:eCE6999. doi: 10.31744/einstein_journal/2021CE6999. eCollection 2022.
Abstract
摘要
相似文献
1
Elimination of SARS-CoV-2 in nasopharynx and oropharynx after use of an adjuvant gargling and rinsing protocol with an antiseptic mouthwash.使用含抗菌漱口水的辅助漱口和冲洗方案后，鼻咽部和口咽部严重急性呼吸综合征冠状病毒2的清除情况
Einstein (Sao Paulo). 2022 Jan 5;19:eCE6999. doi: 10.31744/einstein_journal/2021CE6999. eCollection 2022.
2
Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.在新冠疫情期间，在耳鼻喉科实践中重新利用 0.5%聚维酮碘溶液。
Am J Otolaryngol. 2020 Sep-Oct;41(5):102618. doi: 10.1016/j.amjoto.2020.102618. Epub 2020 Jun 18.
3
Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.口腔抗菌剂对 SARS-CoV-2 病毒载量的影响：一项随机对照试验。
Dent Med Probl. 2022 Jul-Sep;59(3):357-363. doi: 10.17219/dmp/150831.
4
Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.聚维酮碘漱口液、含漱液和鼻腔喷雾剂降低 COVID-19 患者鼻咽部病毒载量的随机临床试验。
JAMA Otolaryngol Head Neck Surg. 2021 Apr 1;147(4):400-401. doi: 10.1001/jamaoto.2020.5490.
5
Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial.新型冠状病毒肺炎患者经口及鼻腔用酞菁口腔抗菌溶液对 SARS-CoV-2 感染力的影响：一项随机对照试验。
Ger Med Sci. 2023 Jun 23;21:Doc07. doi: 10.3205/000321. eCollection 2023.
6
Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476.基于欧洲标准 EN 14476 比较针对 SARS-CoV-2 的不同漱口水溶液的体外疗效。
J Hosp Infect. 2021 May;111:180-183. doi: 10.1016/j.jhin.2021.01.031. Epub 2021 Feb 11.
7
Considerations for povidone-iodine antisepsis in pediatric nasal and pharyngeal surgery during the COVID-19 pandemic.COVID-19 大流行期间儿科鼻腔和咽部手术中聚维酮碘消毒的注意事项。
Am J Otolaryngol. 2020 Nov-Dec;41(6):102737. doi: 10.1016/j.amjoto.2020.102737. Epub 2020 Sep 19.
8
Gargling with povidone iodine has a short-term inhibitory effect on SARS-CoV-2 in patients with COVID-19.用聚维酮碘漱口对新冠肺炎患者体内的新型冠状病毒具有短期抑制作用。
J Hosp Infect. 2022 May;123:179-181. doi: 10.1016/j.jhin.2022.01.001. Epub 2022 Jan 15.
9
Use of oral antiseptics for SARS-CoV-2 infection.口服抗菌剂在新型冠状病毒2感染中的应用。
Med Clin (Barc). 2020 Nov 13;155(9):416-417. doi: 10.1016/j.medcli.2020.07.014. Epub 2020 Jul 27.
10
Recent evidence sustains the use of chlorhexidine-based mouthwash for dental patients during the coronavirus disease 2019 epidemic.近期证据支持在2019冠状病毒病流行期间，为牙科患者使用含氯己定的漱口水。
Am J Orthod Dentofacial Orthop. 2022 Mar;161(3):322-323. doi: 10.1016/j.ajodo.2021.08.017.
引用本文的文献
1
Membrane-Targeting Antivirals.膜靶向抗病毒药物。
Int J Mol Sci. 2025 Jul 28;26(15):7276. doi: 10.3390/ijms26157276.
2
Antiseptics as effective virucidal agents against SARS-CoV-2: Systematic review and Bayesian network meta-analysis.作为对抗新型冠状病毒有效杀病毒剂的防腐剂：系统评价与贝叶斯网络荟萃分析
Jpn Dent Sci Rev. 2025 Dec;61:138-154. doi: 10.1016/j.jdsr.2025.05.001. Epub 2025 Jun 10.
3
Can the use of iron phthalocyanine-derivative mouthrinses in COVID-19 patients provide systemic benefits? Research into this potential should be considered.在新冠肺炎患者中使用铁酞菁衍生物漱口水能否带来全身益处？对此可能性的研究应予以考虑。
GMS Hyg Infect Control. 2024 Oct 2;19:Doc45. doi: 10.3205/dgkh000500. eCollection 2024.
4
Use of phthalocyanine-derived mouthwash as a protective factor for COVID-19: a community trial.使用酞菁衍生漱口水作为COVID-19的保护因素：一项社区试验。
GMS Hyg Infect Control. 2024 Feb 21;19:Doc05. doi: 10.3205/dgkh000460. eCollection 2024.
5
Efficacy of different mouthwashes against COVID-19: A systematic review and network meta-analysis.不同漱口水对新型冠状病毒肺炎的疗效：一项系统评价和网状Meta分析
Jpn Dent Sci Rev. 2023 Dec;59:334-356. doi: 10.1016/j.jdsr.2023.09.003. Epub 2023 Oct 11.
本文引用的文献
1
The use of antiviral Phthalocyanine mouthwash as a preventive measure against COVID-19.使用抗病毒酞菁漱口水作为预防 COVID-19 的措施。
GMS Hyg Infect Control. 2021 Jul 9;16:Doc24. doi: 10.3205/dgkh000395. eCollection 2021.
2
Genome-wide association analysis of COVID-19 mortality risk in SARS-CoV-2 genomes identifies mutation in the SARS-CoV-2 spike protein that colocalizes with P.1 of the Brazilian strain.全基因组关联分析 SARS-CoV-2 基因组中 COVID-19 死亡率风险，鉴定出与巴西变异株 P.1 共定位的 SARS-CoV-2 刺突蛋白突变。
Genet Epidemiol. 2021 Oct;45(7):685-693. doi: 10.1002/gepi.22421. Epub 2021 Jun 22.
3
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil.巴西再次感染 SARS-CoV-2 患者的遗传证据和宿主免疫反应
Emerg Infect Dis. 2021 May;27(5):1446-1453. doi: 10.3201/eid2705.204912. Epub 2021 Apr 12.
4
A Phthalocyanine Derivate Mouthwash to Gargling/Rinsing as an Option to Reduce Clinical Symptoms of COVID-19: Case Series.一种用于漱口/冲洗的酞菁衍生物漱口水作为减轻 COVID-19 临床症状的选择：病例系列
Clin Cosmet Investig Dent. 2021 Feb 18;13:47-50. doi: 10.2147/CCIDE.S295423. eCollection 2021.
5
Potential mouth rinses and nasal sprays that reduce SARS-CoV-2 viral load: What we know so far?能够降低新型冠状病毒2型病毒载量的潜在漱口水和鼻喷雾剂：我们目前所了解的情况？
Clinics (Sao Paulo). 2020 Nov 27;75:e2328. doi: 10.6061/clinics/2020/e2328.
Zotero 插件